Remicade (infliximab) is the first medicine shown to reduce the chance of having the colon removed in people with ulcerative colitis, WebMD reported in October 2007.
It is a biological medicine given by infusion, and at the time it was the only biological approved for moderate to severe ulcerative colitis. It targets the immune system and blocks inflammatory chemicals, especially tumour necrosis factor (TNF). As well as rheumatoid arthritis, it is used for inflammatory bowel diseases, plaque psoriasis, psoriatic arthritis and ankylosing spondylitis.
0
Like
0
Love
0
Angry
0
Dislike
0
